Cargando…
N-Acetyl Cysteine improves the diabetic cardiac function: possible role of fibrosis inhibition
BACKGROUND: Diabetic cardiomyopathy is one of the leading causes of death in diabetes mellitus (DM) patients. This study aimed to explore the therapeutic implication of N-acetyl-L-cysteine (NAC, an antioxidant and glutathione precursor) and the possible underlying mechanism. METHODS: Thirty five 12-...
Autores principales: | Liu, Cong, Lu, Xiao-Zhao, Shen, Ming-Zhi, Xing, Chang-Yang, Ma, Jing, Duan, Yun-You, Yuan, Li-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525750/ https://www.ncbi.nlm.nih.gov/pubmed/26242742 http://dx.doi.org/10.1186/s12872-015-0076-3 |
Ejemplares similares
-
N-acetyl cysteine ameliorates aortic fibrosis by promoting M2 macrophage polarization in aging mice
por: Zhu, Qing-yi, et al.
Publicado: (2021) -
Effect of Local N-acetyl-cysteine in the Prevention of Epidural Fibrosis in Rat Laminectomy Model
por: Bahrami, Reza, et al.
Publicado: (2018) -
N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
por: Martinez-Banaclocha, Marcos
Publicado: (2022) -
N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis
por: Ejigu, Dawit A., et al.
Publicado: (2020) -
N-Acetyl Cysteine Inhibits Endothelin-1-Induced ROS
Dependent Cardiac Hypertrophy through
Superoxide Dismutase Regulation
por: Mushtaq, Sobia, et al.
Publicado: (2015)